Continuing Medical Education for Nurse Practitioners | Earn CME Credit

Education

Search

Beyond Pulmonary

Browse over 450 CME/CE courses on FranceFoundation.com

VIEW ALL EDUCATION

Page 5 of 5

Results 301 - 365 of 365

Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis

Updates on Registry Enrollment and Growth of the Care Center Network

New Approaches to the Diagnosis of IPF

Exploring New Therapeutic Avenues for Managing PF

New Research on Mechanisms in the Development of PF

biosims-gastro1

Biosimilars: The New Era of Gastroenterology Management Considerations

Know Before You Go: IPF Grand Rounds Pre-learning

IPF Management Considerations

Perspectives on Side Effect Management

The Latest in IPF: Implications for Clinical Practice

Registry Data Provide Important Severity Indicators for PH

New Developments in the Diagnosis and Management of IPF

Palliative Care for Patients with IPF

Real World Experience in Patients with COPD

ICD-10 Codes and Nomenclature for Classification of PAH

Fleischner Society Update in Classification of IPF

Transbronchial Cryobiopsy for the Diagnosis of ILD

psoriasis-nurse

Psoriasis Management Considerations: What Would You Do?

psoriasis-case3

Jamie Develops Complications with Her Psoriasis

psoriasis-case2

Psoriasis: Three Case Studies in the Primary Care Setting

psoriasis-case1

Cindy Has a Complex Case of Psoriasis

Optimizing Patient Outcomes in IPF

Famous People with Diabetes: Ella Fitzgerald

Famous People with Diabetes: Jerry Garcia

Comorbidities and Selection of DMTs

The Gut Microbiota in MS

Early MS: Induction Therapy and Escalation Strategies

Vitamin D: Modifiable Risk Factor and its Role in the Management of Patients with MS

t2diabetes-slides1

Download Slides: Optimizing Diabetes Treatment in a Sea of Treatment Options

The Importance of Early Referral and Treatment

How to Recognize and Diagnose IPF

What Is IPF?

What’s Next for IPF Therapy?

Applying the Evidence on Antifibrotic Agents for IPF

What Do the Experts Say about New Developments in the Diagnosis of ILD?

Is the delivery system a good match for your patients with COPD?

Stepping up or stepping down – which direction for COPD patients?

What’s the 2017 GOLD standard for managing patients with COPD?

UIP, IPF, NSIP, CHP: Making Sense of the Letters

t2diabetes-slides2

Download Slides: Advancing T2DM Therapy with Confidence

t2diabetes-louise

Getting to Goal Can Be Difficult: Louise

t2diabetes-brian

Getting to Goal Can Be Difficult: Brian

Considering Biosimilars in Patients Failing their Initial Biologic

When to Switch? Biologically Experienced Patients with Spondyloarthritis

Innovator or Biosimilar for a Patient with Rheumatoid Arthritis

IL-gastro-case3

Ulcerative Colitis: What Can You Expect When a Patient is Switched to a Biosimilar?

IL-gastro-case2

Biosimilars in Patients with Crohn’s Disease Failing an Initial Biologic

IL-gastro-case1

Innovator or Biosimilar for a Patient with Ulcerative Colitis?

Switching Between Biologics: Is a Biosimilar an Option?

FDA Criteria: Biosimilar Approval, Manufacturing, & Naming

What is the Difference Between a Biosimilar and a Generic?

What is a Biologic?

New Strides in EGFR Inhibition for Non–Small Cell Lung Cancer

Pete - Work-Up of a Patient with Right Upper Lobe Mass and Metastases

Carl - High Suspicion of Lung Cancer: Setting the Stage with a Good Biopsy

Are You Ready to Use Biosimilars in Your Practice?

Radiologic Features of IPF

Gwen: A lawyer with a history of MI has a dry cough and trouble with stairs

Individualizing Patient Education in Treatment Choice: Practical Strategies

Biosimilars in Clinical Practice: Interchangeability and Extrapolation

Discovering New Drugs for IPF

New Trends in IPF

New Trends in IPF

Exciting IPF Developments from 2015 ERS

Exciting Developments from 2015 CHEST

Page 5 of 5

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA